• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. NEXGEN TIBIAL TRAY; PROSTHESIS KNEE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. NEXGEN TIBIAL TRAY; PROSTHESIS KNEE Back to Search Results
Model Number N/A
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Adhesion(s) (1695); Loss of Range of Motion (2032); Scar Tissue (2060)
Date of Event 09/08/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4) d10 - medical product: femur trabecular metal cruciate retaining (cr) catalog # 42502806001 lot # 65561098.Articular surface catalog # 00595203014 lot # 64753797.All poly petella catalog # 00597206532 lot # 65937727.Biomet bc r 1x40 us catalog # 110035368 lot # ax46bi1606.H3: customer has indicated that the product will not be returned because it remains implanted.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event or Problem Description
It was reported patient underwent manipulation under anesthesia due to stiffness and arthrofibrosis post implantation.During the procedure the surgeon was able to break up adhesions and scar tissue increasing range of motion.No more information is available.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional information.The following sections were updated: arthrofibrosis is defined as the development of fibrous scar tissue within or surrounding a joint.Arthrofibrosis is a known postoperative procedure related complication that can occur from surgical implantation of new joint replacement as well as from previous injuries or surgical procedures.Scar tissue formation is a normal healing response; however, the buildup of such can result in pain, stiffness, limited range of motion, and difficulty properly ambulating.If excess scar tissue develops, conservative measures such as exercises or physical therapy would be attempted first.If these attempts fail, surgical intervention such as manipulation under anesthesia, arthroscopic arthrolysis, or open arthrotomy would become necessary to remove the fibrous tissue and restore joint function.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event or Problem Description
No further event information available at the time of this report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEXGEN TIBIAL TRAY
Common Device Name
PROSTHESIS KNEE
Manufacturer (Section D)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer (Section G)
ZIMMER BIOMET, INC.
1800 w. center st.
warsaw IN 46580
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key19532467
Report Number0001822565-2024-01995
Device Sequence Number20759351
Product Code MBH
UDI-Device Identifier00889024208247
UDI-Public(01)00889024208247(17)300531(10)64648962
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
K072160
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number00595403701
Device Lot Number64648962
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/23/2024
Supplement Date Received by Manufacturer06/25/2024
Initial Report FDA Received Date06/13/2024
Supplement Report FDA Received Date06/26/2024
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/08/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10 NARRATIVE
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient SexFemale
Patient Weight76 KG
-
-